Vacterial vaginitis, threatened preterm birth
Conditions
Interventions
Give enteric lactoferrin to pregnant women with abnormal vaginal flora
Clinical Trials, Phase II as Topic
Sponsors
Miura Hiroshi
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Maternal age: 20 years old or older, under 50 years 2) Pregnant women who plan to deliver in our department 3) Patients who have been diagnosed with intractable vaginitis or cervicitis, and who have not improved their vaginal discharge findings with conventional treatment
Exclusion criteria
Exclusion criteria: If not gain consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Intractable vagus or cervical inflammation patients improve vaginal discharge findings by taking lactoferrin-enter-soluble tablets 2. Preterm Birth Rate of Pregnant Women With Lactoferrin Enter-Dissolved Tablets | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of side effects and other safety caused by lactoferrin-enter-lytic tablets | — |
Contacts
Public ContactHiroshi Miura
Akita University Hospital
Outcome results
None listed